Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
684
datasets available to search
ShareScore release 0.9.0
Dataset results
684 results for “Head and Neck Squamous Cell Carcinoma”
Mitomycin C in Patients With Incurable p16 Positive Oropharyngeal and p16 Negative Head and Neck Squamous Cell Carcinoma (HNSCC) Resistant to Standard Therapies
ClinicalTrials.gov study NCT02369458. IPD Sharing: NO. Countries: 1. Publications: 0.
Azacitidine and Cisplatin for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT00443261. IPD Sharing: NO. Countries: 1. Publications: 0.
Artificial Intelligence in Functional Imaging for Individualized Treatment of Head and Neck Squamous Cell Carcinoma Patients
ClinicalTrials.gov study NCT05192655. IPD Sharing: YES. Countries: 1. Publications: 0.
IRESSA™ (Gefitinib) With Cisplatin Plus Radiotherapy for the Treatment of Previously Untreated Unresected Late Stage III/IV Non-Metastatic Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT00229723. IPD Sharing: Not stated. Countries: 8. Publications: 0.
Study of RADPLAT and Tarceva in Locally Advanced Head and Neck Squamous Cell Carcinoma (SCCA)
ClinicalTrials.gov study NCT00304278. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Biweekly TPF Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of Head and Neck
ClinicalTrials.gov study NCT04397341. IPD Sharing: NO. Countries: 0. Publications: 1.
Study of Chemotherapy With Cisplatin/Carboplatin, and Docetaxel With or Without Erlotinib in Patients With Head and Neck Squamous Cell Carcinomas Amenable for Surgical Resection
ClinicalTrials.gov study NCT01927744. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of IMC-A12, Alone or in Combination With Cetuximab, in Participants With Recurrent or Metastatic Squamous Cell Carcinoma (MSCC) of the Head and Neck
ClinicalTrials.gov study NCT00617734. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Abemaciclib + Nivolumab in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed or Recurred Within Six Months After Platinum-based Chemotherapy
ClinicalTrials.gov study NCT03655444. IPD Sharing: NO. Countries: 1. Publications: 0.
A Single-arm, Phase II, Multi-center Clinical Trial of Sintilimab During the Perioperative Period in Patients With Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT07379424. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Setanaxib Co-Administered With Pembrolizumab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN)
ClinicalTrials.gov study NCT05323656. IPD Sharing: UNDECIDED. Countries: 7. Publications: 0.
Clinical Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy for Operable Locally Advanced Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT04922450. IPD Sharing: YES. Countries: 1. Publications: 0.
Docetaxel in Combination With Zactima (ZD6474) in Patients With Locally Advanced Squamous Cell Carcinoma of the the Head and Neck
ClinicalTrials.gov study NCT00459043. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ph II Long Term/Low Dose Xeloda in Head and Neck Squamous Cell Carcinoma After Surgery, Radiation & or Chemo
ClinicalTrials.gov study NCT00258310. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ph1 Study of SL-172154 Administered Intratumorally in Subjects With Squamous Cell Carcinoma of the Head and Neck or Skin
ClinicalTrials.gov study NCT04502888. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of GSK3359609 With Pembrolizumab and 5-fluorouracil (5-FU)-Platinum Chemotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT04428333. IPD Sharing: YES. Countries: 19. Publications: 0.
PABLIXIMAB as Neoadjuvant Therapy for Head and Neck Squamous-cell Carcinoma
ClinicalTrials.gov study NCT06125223. IPD Sharing: UNDECIDED. Countries: 0. Publications: 12.
Cetuximab With Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck in Chinese Subjects
ClinicalTrials.gov study NCT01012258. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT03174275. IPD Sharing: NO. Countries: 1. Publications: 0.
Durvalumab (MEDI4736) With Cetuximab in Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT03691714. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.